Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Breast cancer subtype and clinical characteristics in women from Peru.
Zavala VA, Casavilca-Zambrano S, Navarro-Vásquez J, Tamayo LI, Castañeda CA, Valencia G, Morante Z, Calderón M, Abugattas JE, Gómez HL, Fuentes HA, Liendo-Picoaga R, Cotrina JM, Neciosup SP, Roque K, Vásquez J, Mas L, Gálvez-Nino M, Fejerman L, Vidaurre T. Zavala VA, et al. Among authors: mas l. Front Oncol. 2023 Feb 16;13:938042. doi: 10.3389/fonc.2023.938042. eCollection 2023. Front Oncol. 2023. PMID: 36925912 Free PMC article.
Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity.
Gómez H, Mas L, Casanova L, Pen DL, Santillana S, Valdivia S, Otero J, Rodriguez W, Carracedo C, Vallejos C. Gómez H, et al. Among authors: mas l. J Clin Oncol. 1998 Jul;16(7):2352-8. doi: 10.1200/JCO.1998.16.7.2352. J Clin Oncol. 1998. PMID: 9667250 Clinical Trial.
The implementation of the Plan Esperanza and response to the imPACT Review.
Vidaurre T, Santos C, Gómez H, Sarria G, Amorin E, López M, Regalado R, Manrique J, Tarco D, Ayestas C, Calderón M, Mas L, Neciosup S, Salazar M, Chávez JC, Ubillus M, Limache A, Ubillus JC, Navarro J, Sarwal K, Sutcliffe S, Gutiérrez-Aguado A, Silva M, Mena A, Guillén ME, Castañeda C, Abugattas J. Vidaurre T, et al. Among authors: mas l. Lancet Oncol. 2017 Oct;18(10):e595-e606. doi: 10.1016/S1470-2045(17)30598-3. Lancet Oncol. 2017. PMID: 28971826 Review.
[Clinical-pathological features and survival in young women with cervical cancer: a retrospective analysis from the instituto nacional de enfermedades neoplásicas].
Ruiz R, Serrano M, Ruiz EF, Mantilla R, Valdivieso N, Olivera M, Álvarez M, Mas L, Gomez HL. Ruiz R, et al. Among authors: mas l. Rev Peru Med Exp Salud Publica. 2017 Apr-Jun;34(2):218-227. doi: 10.17843/rpmesp.2017.342.2653. Rev Peru Med Exp Salud Publica. 2017. PMID: 29177379 Free article. Spanish.
[Optimal cytoreduction in advanced ovarian cancer treated with dose-dense paclitaxel and carboplatin followed by interval surgery at the Peruvian National Institute of Neoplastic Diseases].
Alcarraz C, Muñiz J, Mas L, Olivera M, Morante Z, Alvarez M, Mantilla R, Araujo J, Pinto J. Alcarraz C, et al. Among authors: mas l. Rev Peru Med Exp Salud Publica. 2018 Jan-Mar;35(1):46-54. doi: 10.17843/rpmesp.2018.351.3599. Rev Peru Med Exp Salud Publica. 2018. PMID: 29924276 Free article. Spanish.
90 results